A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers

Clinical trial NCT01451632 · COMPLETED

Trial details

NCT number: NCT01451632
Sponsor: Merrimack Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Squamous Cell Head and Neck Cancer Non-small Cell Lung Cancer Triple Negative Breast Cancer Other Tumors With EGFR Dependence

Start date: 2011-10-01
Primary completion: 2013-11-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.